Clinical trial
Evaluation of Serum BRCC36 and Telomerase Levels in Women With Polycystic Ovary Syndrome
NCT07849166 is registered in ClinicalTrials.gov with Cumhuriyet University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Serum BRCC36 and Telomerase Levels in Women With Polycystic Ovary Syndrome
- Lead sponsor
- Cumhuriyet University
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 20, 2024
- Completion date
- May 1, 2026
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
polycystic ovarian syndrome (pcos)